Don’t miss this opportunity to be heard.
The Standards Coordinating Body for Regenerative Medicine (SCB) will be hosting a two-hour Webinar on August 24, 2022, at 12:00 pm EST to discuss the recently released FDA guidance on CBER’s Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies. In this webinar, SCB will explain the draft guidance document and collect and coordinate participant comments for submission to the FDA.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
